Back
EACVI 2025 Premium Access

4D Flow CMR in the assessment of residual mitral regurgitation after TEER: correlation with left ventricular reverse remodelling using multiple CMR quantification methods

Session: Cardiovascular magnetic resonance in valvular heart disease
Topic: Valvular Heart Disease
Speaker: Doctor K. Stankowski (Milan, IT)
Event: EACVI 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Kamil Stankowski

Monzino Cardiology Centre, Milan (Italy)
2 presentations
0 follower

6 more presentations in this session

Functional versus anatomical method for defining the LV base by CMR in Barlow's disease: what is the best approach for quantifying mitral regurgitation?

Speaker: Doctor S. Leboube (Lausanne, CH)

Access
Abstract
Slides
Like
Thumbnail

Myocardial fibrosis on LGE MRI is associated with accelerated progression of aortic stenosis

Speaker: Doctor K. Hirata (Kishiwada, JP)

Access
Abstract
Slides
Like
Thumbnail

Right ventricular-pulmonary arterial coupling in patients with tricuspid regurgitation: a new cardiac magnetic resonance quantification method

Speaker: Doctor D. Escribano Garcia (Barcelona, ES)

Access
Abstract
Slides
Like
Thumbnail

The impact of aortic distensibility in patients with bicuspid aortic valve stenosis

Speaker: Doctor J. Abecasis (Lisbon, PT) Doctor D. Da Silva Correia (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Left atrioventricular coupling in pediatric patients with isolated mitral valve prolapse, preserved ejection fraction and moderate degree of mitral regurgitation.

Speaker: Doctor F. Shokeir (Mansoura, EG)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Cardiovascular magnetic resonance in valvular heart disease

Speakers: Doctor K. Stankowski, Doctor S. Leboube, Doctor K. Hirata, Doctor D. Escribano Garcia, Doctor J. Abecasis...
Access
Like
Thumbnail

About the event

Image

EACVI 2025

11 December - 13 December 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources